# A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

> **NCT04797793** · EARLY_PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 978 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene Gel 0.1%
- **DRUG:** Placebo Control
- **DRUG:** Differin® Gel (Adapalene 0.1%, Galderma)

## Key facts

- **NCT ID:** NCT04797793
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2021-01-08
- **Final completion:** 2021-01-08
- **Target enrollment:** 978 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04797793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04797793, "A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04797793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*